動画検索
関連広告
検索結果
In this segment, panelists discuss the role of the TKI lapatinib in the adjuvant, neoadjuvant, and metastatic setting for patients with ...
YouTube-OncLiveTV
2014/03/17Prof Harrington talks to ecancertv at ASCO 2014 about a phase III study of adjuvant postoperative lapatinib with concurrent chemotherapy and ...
ecancer
2014/06/02Julia White, MD, professor of Radiation Oncology, Ohio State University, discusses a phase II study of whole brain radiotherapy with ...
YouTube-Targeted Oncology
2016/12/22拉帕替尼改善CTC HER2阳性转移性乳腺癌患者总生存 · 2024年北京大学肿瘤医院护理进修招生简章 · 北京肿瘤医院2023年财政预算信息公开 · 研究专利 · I期临床试验病区简介及 ...
北京大学肿瘤医院
2023/08/11拉帕替尼改善CTC HER2阳性转移性乳腺癌患者总生存 · 2024年北京大学肿瘤医院护理进修招生简章 · 我院成功举办全国肿瘤免疫治疗及护理新进展学习班 · 北京肿瘤医院2023年 ...
北京大学肿瘤医院
2023/09/11... lapatinib, pertuzumab, and T-DM1. Each of these agents has a unique mechanism of targeting HER-2 signaling and cross-talk among HER family ...
YouTube-HMP Education
2013/04/30拉帕替尼改善CTC HER2阳性转移性乳腺癌患者总生存 · 2024年北京大学肿瘤医院护理进修招生简章 · 北京肿瘤医院2023年财政预算信息公开 · 研究专利 · I期临床试验病区简介及 ...
北京大学肿瘤医院
2023/08/16Lapatinib is given with chemotherapy or after other methods have not worked to slow the cancer. Lapatinib is for HER2 positive breast ...
National Breast Cancer Foundation-National Breast Cancer Foundation
2024/01/17... lapatinib studies with regard to the risk of relapse and death and the optimal treatment duration of adjuvant trastuzumab. She also explores ...
YouTube-European Society for Medical Oncology (ESMO)
2021/10/12... lapatinib showed increased pCR rates compared to lapatinib alone. The impact of TILs varied by estrogen receptor status, suggesting ...
VJOncology-VJOncology
1日前Patrick Y. Wen MD interview on Video originally published on PracticeUpdate.com on 02/01/2021 ...
YouTube-PracticeUpdate
2021/02/15This video shows you how to pronounce Lapatinib.
YouTube-Pronunciation Guide
2015/05/29lapatinib studies regarding the risk of relapse and death, and the optimal treatment duration of adjuvant trastuzumab. She also explores the ...
Facebook-ESMO - European Society for Medical Oncology
2021/10/14Originally aired February, 2013 Presented by: Joanna Barbara, Ph.D. Metabolism-dependent inhibition of cytochrome P450 enzymes has the ...
YouTube-XenoTech
2023/02/21動画の見どころ1/10枚目 Housekeeping
動画の見どころ2/10枚目 Dr Joanna Babaro
動画の見どころ3/10枚目 Cytochrome P450 Inhibition
動画の見どころ4/10枚目 Irreversible Inhibition
動画の見どころ5/10枚目 Trianomycin
動画の見どころ6/10枚目 Metabolite Profiling
動画の見どころ7/10枚目 Accurate Mass Spectrometry Approach
動画の見どころ8/10枚目 Fragmentation Data
動画の見どころ9/10枚目 Question and Answers
動画の見どころ10/10枚目 Wrap Up
... lapatinib studies with regard to the risk of relapse and death and the optimal treatment duration of adjuvant trastuzumab. She also explores ...
OncologyPRO-European Society for Medical Oncology (ESMO)
2021/10/12Understanding the Pathway article: http://ascopubs.org/doi/full/10.1200/JCO.2014.55.7652 The Journal of Clinical Oncology's "Understanding ...
YouTube-ASCOcancer
2016/12/02肿瘤瞭望网版权所有，谢绝任何形式转载，侵犯版权者必予法律追究。 相关搜索. 化疗HER-2阳性帕妥珠单抗拉帕替尼. 精彩推荐. ASH 2023丨李春蕊教授：伊基奥仑赛（C.. ASH ...
肿瘤瞭望
2014/09/09甲苯磺酸拉帕替尼. 吉西他滨. 本品主要成份为：利奥西呱. 乙磺酸尼达尼布. 阿伦单抗. 雷莫司琼 ... 拉帕替尼（lapatinib). avelumab. 西妥昔单抗（cetuximab）. CPX-351. 顺 ...
良医汇
2017/06/01Clinical trials of new breast cancer drug lapatinib.
ecancer
2008/12/03甲苯磺酸拉帕替尼. 吉西他滨. 活性成份：恩他卡朋. 胸腺肽α1. 重组人粒细胞刺激因子其来源. 重组 ... 拉帕替尼（lapatinib). avelumab. 西妥昔单抗（cetuximab）. CPX-351.
良医汇
2017/05/25